Campus Alert

Resources for DBMI’s International Scholars & Students

We have posted a list of resources provided by the Harvard International Office

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial.

Lee SH, Lee JK, Ahn MJ, Kim DW, Sun JM, Keam B, Kim TM, Heo DS, Ahn JS, Choi YL, Min HS, Jeon YK, Park K.

Ann Oncol

February 1, 2017

http://www.ncbi.nlm.nih.gov/pubmed/27803005

28(2):292-297

https://connects.catalyst.harvard.edu/Profiles/profile/78538815

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial.

Lee SH, Lee JK, Ahn MJ, Kim DW, Sun JM, Keam B, Kim TM, Heo DS, Ahn JS, Choi YL, Min HS, Jeon YK, Park K.

Ann Oncol

February 1, 2017

http://www.ncbi.nlm.nih.gov/pubmed/27803005

28(2):292-297

https://connects.catalyst.harvard.edu/Profiles/profile/78538815